CHD7 |
chd7 |
CHARGE |
MO |
Abnormal somite segmentation (13 somite)
Small eyes, pericardial edema, abnormal otoliths (48 hpf)
Abnormal vascular patterning (48 hpf), cranial neural crest (34 –36 hpf), cranial neuron (48 hpf), and retinal (72 hpf) development; decreased bone mineralization (8 dpf, 14 dpf)
|
Zebrafish mRNA rescues eye, heart, and otolith abnormalities |
Patten et al. (2012) |
|
|
|
MO |
Developmental defects as in Patten et al. (2012)
Decreased cell proliferation (25 hpf)
Abnormal craniofacial cartilage (4 dpf)
|
fbxl10 MO reduced developmental defects, cell proliferation deficit |
Balow et al. (2013) |
|
|
|
MO
CRISPR Mutant
|
chd7 −/− mutants and chd7 MO:
-
-
Pericardial edema, cardiomegaly (3 dpf); abnormal pigmentation (4 dpf)
-
-
Reduction of vagal innervation of GI tract in foregut more than hindgut (5 dpf)
-
-
Decreased GI emptying (5 dpf)
|
Prokinetic drugs do not rescue GI emptying |
Cloney et al. (2018) |
CHD8 |
chd8 |
ASD |
MO;
F0
CRISPR
|
Macrocephaly (increased interorbital/intertectal distance (4.3 dpf) in MO; increased interorbital distance in F0 CRISPR)
Developmental marker expression changes: expansion of chordin (shield stage); increased mid/forebrain neuronal progenitor marker otx2 (tail bud) and dlx2 in prethalamus (24 hpf; MO)
Decreased GI motility (MO) and # of enteric neurons (6 dpf; MO and F0 CRISPR)
|
− |
Bernier et al. (2014) |
|
|
|
MO |
|
− |
Sugathan et al. (2014) |
CNTNAP2 |
cntnap2a/b |
ASD EP CDFE |
ZFN
Mutant
|
Decreased forebrain GABAergic neurons (4 dpf)
Increased sensitivity to drug-induced seizures; nighttime hyperactivity (4–6 dpf)
GABA-modifying drugs induce differential behavioral responses
Increased sensitivity to behavioral activation by NMDA antagonists
|
Estrogenic compounds identified in drug screen rescue nighttime hyperactivity |
Hoffman et al. (2016) |
DYRK1A |
dyrk1aa |
ASD |
TALEN
Mutant
|
Normal development, morphology (24–48 hpf); normal larval locomotor activity (5–7 dpf)
No difference in brain size (2 weeks old); increased apoptosis in brain (3 weeks old)
Adult Phenotypes: Microcephaly; decreased anxiety, social behavior impairments, decreased c-fos, crh expression in hypothalamic regions after social interaction, social isolation, respectively
|
− |
Kim et al. (2017) |
FMR1 |
fmr1 |
FXS |
MO
OE
|
fmr1 MO:
-
-
Abnormal mid-hindbrain boundary, altered dlx2a expression (24 hpf)
-
-
Increased branching of trigeminal and Rohon-Beard neurites (24 hpf)
-
-
Axon defasciculation of lateral longitudinal fasciculus (5 dpf)
-
-
Fewer trigeminal neurons; craniofacial abnormalities (5 dpf)
|
fmr1 mRNA rescues dlx2a expression; MPEP rescues neurite branching, number of trigeminal neurons |
Tucker et al. (2006) |
|
|
|
|
|
|
|
|
|
|
TILLING
Mutant
|
|
− |
den Broeder et al. (2009) |
MECP2 |
mecp2 |
RTT |
TILLING
Mutant
|
Increased contractions during coiling events (25 hpf)
Increased C-bend duration during escape response (51 hpf)
Decreased locomotor activity and thigmotaxis (6 dpf)
|
− |
Pietri et al. (2013) |
MECP2 |
mecp2 |
RTT |
MO;
F0
CRISPR;
OE
|
mecp2 MO:
-
-
Increased neural, glial proliferation; decreased differentiation (48 hpf) (MO and F0 CRISPR)
-
-
Upregulation of Notch signaling genes; increased brain her2, id1 expression (48 hpf)
mecp2 OE:
-
-
Decreased cell proliferation, increased neuronal differentiation (48 hpf)
-
-
Decreased id1 expression (48 hpf)
|
mecp2 mRNA, her2 MO, id1 MO rescue proliferation, differentiation phenotypes in mecp2 MO; id1 MO rescues her2 levels in mecp2 MO |
Gao et al. (2015) |
|
|
|
MO;
TILLING
Mutant
|
mecp2−/− mutant and mecp2 MO:
-
-
Decreased trigeminal neurite length (24 hpf); less severe in mutant
-
-
Downregulation of sema3f, sema5b and robo2 (24 hpf); less severe in mutant
-
-
MO + mutant does not worsen mutant phenotypes
|
Zebrafish mecp2 mRNA rescues neurite length; HuC-mecp2, sema5b, robo2 mRNA rescue neurite length and tactile response phenotypes |
Leong et al. (2015) |
|
|
|
MO |
Decreased Rohon-Beard axon length/branching (28 hpf)
Motor neuron axon abnormalities: caudal primary (28 hpf), caudal secondary (72 hpf)
Decreased touch response (28 hpf, 72 hpf)
Increased bdnf expression (24 hpf)
Increased presynaptic SV2-stained area, abnormal formation of neuromuscular junction (72 hpf; also in bdnf OE); bdnf MO decreases presynaptic area in mecp2 MO
|
Human MECP2 mRNA rescues motor axon, touch response phenotypes; MECP2 lacking MBD domain does not rescue |
Nozawa et al. (2017) |
|
|
|
TILLING
Mutant
|
Body length: decreased at 2 dpf; normal at 7 dpf
GI tract discoloration, abnormal droplets (4 dpf, 7 dpf)
Expression of inflammatory marker crp: normal at 3 dpf; increased at 4–5 dpf
|
mecp2 OE partially rescues tnfa expression (24 hpf); tnfa OE does not rescue body length, GI-associated neutrophil number (2–3 dpf) |
van der Vaart et al. (2017) |
|
|
|
|
Neutrophil number: normal at 3 dpf, increased at 4–5 dpf; increased in GI tract (2–5 dpf)
Dysregulated cytokine expression; decreased tnfa expression (6 hpf, 24 hpf–7 dpf)
No tnfa activation during acute inflammation (3 dpf)
|
|
|
SHANK3 |
shank3a |
ASD PMS |
MO |
Abnormal mid-hindbrain boundary, ventricle size (28–30 hpf)
Increased apoptosis in CNS (reversed by p53 MO) (24–28 hpf)
Decreased GABAergic neurons (mid/hindbrain), glutamatergic neurons (hindbrain; 48 hpf)
Abnormal escape responses and seizure-like behaviors (72 hpf)
|
Human SHANK3 mRNA partially rescues apoptosis |
Kozol et al. (2015) |
|
shank3b |
|
CRISPR
Mutant
|
Transient developmental delay (24 hpf)
Decreased HuC:RFP levels (24–72 hpf), though difference decreases over time
Decreased locomotor activity (7 dpf)
Adult Phenotypes: Increased brain size, decreased locomotor activity/thigmotaxis, social behavior impairments, repetitive behaviors, decreased brain homer1, synaptophysin levels
|
− |
Liu et al. (2018) |
SYNGAP1 |
syngap1b |
ASD |
MO |
Abnormal mid-hindbrain boundary, ventricle size (28–30 hpf)
Increased apoptosis in CNS (not reversed by p53 MO) (24–28 hpf)
Microcephaly, developmental delay (48–72 hpf)
Decreased GABAergic neurons in midbrain, glutamatergic neurons in hindbrain (48 hpf)
Abnormal escape responses and seizure-like behaviors (72 hpf)
|
Human SYNGAP1 mRNA partially rescues apoptosis |
Kozol et al. (2015) |
TSC1 |
tsc1a |
TSC |
MO |
Body curvature, cysts in tubular/glomerular regions of pronephros
Decreased left-right asymmetry; increased TOR activity (24 hpf), ciliary length (20–24 hpf)
|
− |
DiBella et al. (2009) |
TSC2 |
tsc2 |
TSC |
TILLING
Mutant;
OE;
Cell
transplantation
|
tsc2−/−:
-
-
Deflated swim bladder, enlarged liver, increased TORC1 activity (7 dpf); death by 11 dpf
-
-
Increased size of hepatocytes (9 dpf), brain and spinal cord neurons (7.5 dpf)
-
-
Forebrain gray and white matter disorganization, ectopic neurons in white matter (7.5 dpf)
Cell transplantation of tsc2−/− cells into wild-type at 4 hpf:
-
-
Increased TORC1 activity in mutant, not wild-type, cells (7.5 dpf; adult)
-
-
Disrupted gray-white matter boundaries (7.5 dpf; adult)
-
-
Ectopic wild-type cells in white matter in some chimeric embryos (7.5 dpf)
-
-
Mutant cell clusters found in gray-white matter boundary, gray matter (adult)
|
Zebrafish mRNA rescues elevated TORC1 activity (partial rescue by human mRNA); rapamycin reverses elevated TORC1 activity |
Kim et al. (2011) |